Risk Factors, Treatment and Prognosis of Patients with Lung Cancer after Heart Transplantation

Risk Factors, Treatment and Prognosis of Patients with Lung Cancer after Heart Transplantation

Long-term survival after heart transplantation (HTX) is impacted by adverse effects of immunosuppressive pharmacotherapy, and post-transplant lung cancer is a common occurrence. This study aimed to examine the risk factors, treatment, and prognosis of patients with post-transplant lung cancer. We in...

Full description

Bibliographic Details
Main Authors: Karsten M. Heil, Matthias Helmschrott, Fabrice F. Darche, Tom Bruckner, Philipp Ehlermann, Michael M. Kreusser, Andreas O. Doesch, Wiebke Sommer, Gregor Warnecke, Norbert Frey, Rasmus Rivinius
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Life
Subjects:
heart transplantation
immunosuppression
malignancy
mortality
lung cancer
survival
Online Access:https://www.mdpi.com/2075-1729/11/12/1344

Internet

https://www.mdpi.com/2075-1729/11/12/1344

Similar Items